Effects of dried okra extract on lipid profile, renal function and some RAGE-related inflammatory genes expression in patients with diabetic nephropathy: A randomized controlled trial

Background: Diabetic nephropathy (DN) is a common complication of type 2 diabetes. Okra (Abelmoschus esculentus L) is reported to have anti-diabetic effects. The present study aimed to investigate the effects of dried okra extract (DOE) supplementation on lipid profile, renal function indices, and e...

Full description

Bibliographic Details
Main Authors:	Nazgol Bahreini, Maryam Saghafi-Asl, Omid Nikpayam, Ehsan Safaei, Vahideh Sadra, Laleh Fakhr, Hanieh Beyrampour-Basmenj, Parina Asgharian, Mohammad Asghari- Jafarabadi
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Series:	Complementary Therapies in Medicine
Subjects:	Diabetic nephropathy Okra (Abelmoschus esculentus L) Receptor for advanced glycation end products Soluble Receptor for advanced glycation end products Intercellular adhesion molecules Interleukin 1 beta
Online Access:	http://www.sciencedirect.com/science/article/pii/S0965229924000153

Similar Items

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)

The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
by: Niki L. Reynaert, et al.
Published: (2023-05-01)

Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
by: Yu Peng, et al.
Published: (2022-12-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
by: Taehee Kim, et al.
Published: (2023-05-01)

Humoral factors in the formation of neuroosteoarthropathy in type 2 diabetes mellitus
by: M. M. Kalandiya, et al.
Published: (2023-12-01)

RAGE is a critical factor of sex-based differences in age-induced kidney damage
by: Seerat Bajwa, et al.
Published: (2023-03-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01)

Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE
by: Hee-Weon Lee, et al.
Published: (2021-09-01)

The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway
by: Liuyang Ren, et al.
Published: (2021-01-01)

Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study
by: Yu Wing Tong, et al.
Published: (2023-05-01)

Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner
by: Seigmund Wai Tsuen Lai, et al.
Published: (2024-01-01)

RAGE-Dependent Effect of Exogenous Methylglyoxal Intake on Lung Biomechanics in Mice
by: Samiya Al-Robaiy, et al.
Published: (2022-12-01)

RAGE Signaling in Melanoma Tumors
by: Olamide T. Olaoba, et al.
Published: (2020-11-01)

The Patient’s Physiological Status at the Start Determines the Success of the Inpatient Cardiovascular Rehabilitation Program
by: Anna Odrovicsné-Tóth, et al.
Published: (2023-02-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

Haplotype Analysis of RAGE Gene Polymorphisms and Association with Increased Risk of Diabetic Nephropathy
by: Abbas Tavakoli, et al.
Published: (2022-01-01)

RAGE displays sex-specific differences in obesity-induced adipose tissue insulin resistance
by: Zuoqin Du, et al.
Published: (2022-11-01)

Sulforaphane Inhibits MGO-AGE-Mediated Neuroinflammation by Suppressing NF-κB, MAPK, and AGE–RAGE Signaling Pathways in Microglial Cells
by: Lalita Subedi, et al.
Published: (2020-08-01)

Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes
by: James N. Tsoporis, et al.
Published: (2020-11-01)

RAGE contributes to allergen driven severe neutrophilic airway inflammation via NLRP3 inflammasome activation in mice
by: Katherine N. Killian, et al.
Published: (2023-01-01)

Suppression of RAGE and TLR9 by Ketamine Contributes to Attenuation of Lipopolysaccharide-Induced Acute Lung Injury
by: Chunyan Yang, et al.
Published: (2017-05-01)

The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes
by: Matthew Snelson, et al.
Published: (2022-02-01)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
by: Elena Dozio, et al.
Published: (2021-10-01)

Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer
by: Ziling Mao, et al.
Published: (2021-12-01)

Changes of RAGE/p38MAPK/NF-κB signaling pathway in brain tissue of subchronic fluorosis rats and protective effects of Ginkgo biloba extract and RAGE antagonist
by: Qiuzhe LIANG, et al.
Published: (2023-05-01)

RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin
by: Adriana Machado-Lima, et al.
Published: (2020-10-01)

High BAL sRAGE is Associated with Low Serum Eosinophils and IgE in Children with Asthma
by: Jason T. Patregnani, et al.
Published: (2020-08-01)

Effect of a Topical Collagen Tripeptide on Antiaging and Inhibition of Glycation of the Skin: A Pilot Study
by: Young In Lee, et al.
Published: (2022-01-01)

RAGE as a Novel Biomarker for Prostate Cancer: A Systematic Review and Meta-Analysis
by: Catherine C. Applegate, et al.
Published: (2023-10-01)

Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors
by: Wenge Zheng, et al.
Published: (2022-11-01)

Do advanced glycation end products contribute to food allergy?
by: P. K. Smith, et al.
Published: (2023-04-01)

Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease
by: Melpomeni Peppa, et al.
Published: (2021-09-01)

DAMPs and RAGE Pathophysiology at the Acute Phase of Brain Injury: An Overview
by: Baptiste Balança, et al.
Published: (2021-02-01)

Calprotectin and Receptor for Advanced Glycation End Products as a Potential Biomarker in Abdominal Aortic Aneurysm
by: Willy Hauzer, et al.
Published: (2020-03-01)

Association of SARS-CoV-2 nucleocapsid viral antigen and the receptor for advanced glycation end products with development of severe disease in patients presenting to the emergency department with COVID-19
by: Zachary A. Matthay, et al.
Published: (2023-03-01)

Effect of transferrin glycation induced by high glucose on HK-2 cells in vitro
by: Yanqi Ma, et al.
Published: (2023-01-01)

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant
by: Ingrid Fricke-Galindo, et al.
Published: (2024-04-01)